Skip to main content

Table 2 Comparison of Outcome Measures Between Moxibustion and Control

From: Moxibustion for cephalic version: a feasibility randomised controlled trial

  Moxibustion (as referent) Control Relative Risk (95% CI) P value
  N = 10 N = 10   
Cephalic presentation (at delivery or before ECV) 2 (20.0) 0 (0) 5.0 (0.27-92.62 0.28
Cephalic presentation at delivery (including successful ECV) 5 (50.0) 1 (10.0) 5.0 (0.70-35.5) 0.11
ECV     
   Attempted 4 (40.0) 6 (60.0) 0.67 (0.27-1.66) 0.38
   Successful* 2 (20.0) 0 (0.0) 5.0 (0.27-95.62) 0.28
Mode of delivery     
   Vaginal 4 (40.0) 1 (10.0) 4.0 (0.54-29.8) 0.18
   Caesarean 6 (60.0) 9 (90.0) 0.67 (0.39-1.15) 0.15
Other outcomes     
   Preterm birth requiring hospitalisation 2 (20.0) 0 (0) 5.0 (0.27-92.62) 0.28
   Prelabour rupture of membranes at < 37 weeks 3 (30.0) 0 (0) 7.0 (0.41, 120.16) 0.18
Gestational age at delivery 38.7 (2.11) 39.9 (3.68)   0.43
Apgar score < 7 at 5 min 0 (0) 0 (0) N/A  
Birthweight (g) 3224 (653.9) 3193 (674)   0.92
Admission to NICU 2 (20.0) 0 (0) N/A  
  1. Data are n (%) or mean (standard deviation) unless otherwise specified.* Calculated among women attempting ECV